Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Simultaneous Activity of MRP1 and Pgp Is Correlated With In Vitro Resistance to Daunorubicin and With In Vivo Resistance in Adult Acute Myeloid Leukemia
1999
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
1999
Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins
2000
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)
2002
Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer
2000
P‐glycoprotein, lung resistance‐related protein and multidrug resistance associated protein in de novo acute non‐lymphocytic leukaemias: biological and clinical implications
1999
Aggressive Cutaneous NK and NK-like T-Cell Lymphomas
1999
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)
2001
P‐glycoprotein (PGP), lung resistance‐related protein (LRP) and multidrug resistance‐associated protein (MRP) expression in acute promyelocytic leukaemia
2000
Primary Cutaneous CD8-Positive Epidermotropic Cytotoxic T Cell Lymphomas
1999
Histopathological Standards for the Diagnosis of Gastrointestinal Inflammation in Endoscopic Biopsy Samples from the Dog and Cat: A Report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group
2008 Standout
Vaults: a ribonucleoprotein particle involved in drug resistance?
2003
Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
2001 Standout
Molecular characterisation of soft tissue tumours: a gene expression study
2002 Standout
Crohn's disease
2012 Standout
Subcutaneous Panniculitis-like T-Cell Lymphoma
1998
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Genomic Variation of Human Papillomavirus Type 16 and Risk for High Grade Cervical Intraepithelial Neoplasia
1997
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Targeting multidrug resistance in cancer
2006 Standout
T-Cell and NK-Cell Posttransplantation Lymphoproliferative Disorders
2007
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Hepatosplenic ɑß T-Cell Lymphomas
2001
Feline Large Granular Lymphocyte (LGL) Lymphoma with Secondary Leukemia: Primary Intestinal Origin with Predominance of a CD3/CD8αα Phenotype
2006
Protecting the myocardium: A role for the β2 adrenergic receptor in the heart
2004 StandoutNobel
Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome
2004
Expression of Functional Markers in Acute Nonlymphoblastic Leukemia
2000
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
2010
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:
2004
Acute Myeloid Leukemia
1999
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Structure of the vault, a ubiquitous celular component
1999
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.
1994
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
2000 Standout
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
The Role of ABC Transporters in Clinical Practice
2003
Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
1997
Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological findings of four cases
1998
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
γδ T‐cell lymphomas: a homogeneous entity?
2000
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
TELOMERES AND THEIR CONTROL
2000 StandoutNobel
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
2000
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
1997
VX-710 (Biricodar) Increases Drug Retention and Enhances Chemosensitivity in Resistant Cells Overexpressing P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance Protein
2004
Biology of Gastrointestinal Stromal Tumors
2004 Standout
The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
2014
Mechanisms of Cancer Drug Resistance
2002 Standout
Identification of Pancreatic Cancer Stem Cells
2007 Standout
Nonnasal Lymphoma Expressing the Natural Killer Cell Marker CD56: A Clinicopathologic Study of 49 Cases of an Uncommon Aggressive Neoplasm
1997
Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane inEgr-1deficient female mice
2001
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator
2005
Diffuse large cell lymphoma
2011
Multidrug resistance in human tumors—molecular diagnosis and clinical significance
1999
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies
2004
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Works of JP Greer being referenced
Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma
2000
High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia
1997
Phase I trial with recombinant human interleukin-3 in patients with lymphoma undergoing autologous bone marrow transplantation
1993
Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes [see comments]
1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia
1996